Product Recalls in Idaho

Product recalls affecting Idaho — including food, drugs, consumer products, medical devices, and vehicles distributed to Idaho. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,614 recalls have been distributed to Idaho in the last 12 months.

48,215 total recalls
2,614 in last 12 months

Showing 10211040 of 13,381 recalls

DrugMay 23, 2024· Eugia US LLC

Recalled Item: Dexamethasone Sodium Phosphate injection USP Recalled by Eugia US LLC Due to...

The Issue: Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 23, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Zoledronic Acid Injection 5mg/100mL Sterile Solution Recalled by Dr. Reddy's...

The Issue: Lack of Assurance of Sterility: Leaking vials

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 22, 2024· MexHealth LLC

Recalled Item: OSSOS-SANS con: Glucosamina Curcuma Ortiga tablets Recalled by MexHealth LLC...

The Issue: Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 22, 2024· Eugia US LLC

Recalled Item: Eptifibatide injection 20mg/10mL (2mg/mL) Recalled by Eugia US LLC Due to...

The Issue: Failed Impurities/Degradation Specifications: failed related substance...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 20, 2024· Genentech, Inc.

Recalled Item: Cathflo activase (ALTEPLASE) Recalled by Genentech, Inc. Due to Lack of...

The Issue: Lack of Assurance of Sterility: Deformed stoppers observed during filling...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 20, 2024· Pfizer Inc.

Recalled Item: Labetalol Hydrochloride Injection Recalled by Pfizer Inc. Due to Lack of...

The Issue: Lack of Assurance of Sterility-The potential for incomplete crimp seals.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 20, 2024· Pfizer Inc.

Recalled Item: Buprenorphine Hydrochloride Injection Recalled by Pfizer Inc. Due to Lack of...

The Issue: Lack of Assurance of Sterility-The potential for incomplete crimp seals.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 17, 2024· Breckenridge Pharmaceutical, Inc

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 17, 2024· GlaxoSmithKline LLC

Recalled Item: Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension Recalled by...

The Issue: Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 16, 2024· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Estradiol Transdermal System Recalled by Zydus Pharmaceuticals (USA) Inc Due...

The Issue: Failed Impurities/Degradation Specifications.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 16, 2024· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Estradiol Transdermal System Recalled by Zydus Pharmaceuticals (USA) Inc Due...

The Issue: Failed Impurities/Degradation Specifications.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 16, 2024· Rising Pharma Holding, Inc.

Recalled Item: Pregabalin Capsules 50mg Recalled by Rising Pharma Holding, Inc. Due to...

The Issue: Presence of Foreign Tablets/Capsules: Complaint received from a re-packager,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 15, 2024· Regeneron Pharmaceuticals Inc

Recalled Item: EYLEA Recalled by Regeneron Pharmaceuticals Inc Due to Lack of Assurance of...

The Issue: Lack of Assurance of Sterility: Complaints of syringe breakage

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension Recalled...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Moxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Klarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion 0.1%...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL Recalled by Imprimis NJOF, LLC...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Dexamethasone-Moxifloxacin (1 mg/mL and 5mg/mL) Preservative-Free Recalled...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund